PT  - JOURNAL ARTICLE
AU  - Bryan Valcarcel
AU  - Jose L. Avilez
AU  - J. Smith Torres-Roman
AU  - Julio A. Poterico
AU  - Janina Bazalar-Palacios
AU  - Carlo La Vecchia
TI  - The effect of early-stage public health policies on the transmission of COVID-19 in South American countries
AID  - 10.1101/2020.08.09.20149286
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.09.20149286
4099  - http://medrxiv.org/content/early/2020/08/25/2020.08.09.20149286.short
4100  - http://medrxiv.org/content/early/2020/08/25/2020.08.09.20149286.full
AB  - Objectives The analysis of transmission dynamics is crucial to determine whether mitigation or suppression measures reduce the spread of Coronavirus disease 2019 (COVID-19). This study sought to estimate the basic (R0) and time-varying (Rt) reproduction number of COVID-19 and contrast the public health measures for ten South American countries.Methods Data was obtained from the European Centre for Disease Prevention and Control. Country-specific R0 estimates during the first two weeks of the outbreak and Rt estimates after 90 days were estimated.Results Countries used a combination of isolation, physical distancing, quarantine, and community-wide containment measures to staunch the spread of COVID-19 at different points in time. R0 ranged from 1.52 (95% confidence interval: 1.13-1.99) in Venezuela to 3.83 (3.04-4.75) in Chile, whereas Rt after 90 days ranged from 0.71 (95% credible interval: 0.39-1.05) in Uruguay to 1.20 (1.19-1.20) in Brazil. Different R0 and Rt values may be related to the testing capacity of each country.Conclusion R0 in the early phase of the outbreak varied across the South American countries. The public health measures adopted in the initial period of the pandemic appear to have reduced Rt over time in each country, albeit to different levels.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialEcological studyFunding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is an Ecological study IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is freely available https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide